Gyre Therapeutics (GYRE) Other financing activities (2010 - 2025)
Gyre Therapeutics (GYRE) reported Other financing activities of -$315000.0 for Q3 2025, down 730.0% year-over-year from $50000.0 in Q3 2024, and down 118.74% quarter-over-quarter from $1.7 million in Q2 2025.
Gyre Therapeutics (GYRE) Other financing activities (2010 - 2025) Analysis & Trends
Gyre Therapeutics (GYRE) has 7 years of Other financing activities data on file, last reported at -$315000.0 in Q3 2025.
- Other financing activities for Q3 2025 came in at -$315000.0, down 730.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (up 34.94% YoY), and the FY2025 annual result was $1.5 million, up 177.43% from the prior year.
- Other financing activities fell to -$315000.0 in Q3 2025 per GYRE's latest filing, from $1.7 million in the prior quarter.
- Over five years, Other financing activities peaked at $1.7 million in Q2 2025 and troughed at -$315000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -315,000.00 |
| Sep 30, 2025 | -315,000.00 |
| Jun 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 121,000.00 |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 367,000.00 |
| Dec 31, 2024 | 367,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Dec 31, 2017 | 403,000.00 |
| Dec 31, 2017 | 403,000.00 |
| Sep 30, 2017 | 282,000.00 |
| Sep 30, 2017 | 282,000.00 |
| Jun 30, 2017 | 6.88 Mn |
| Jun 30, 2017 | 6.88 Mn |
| Mar 31, 2017 | 6.75 Mn |
| Mar 31, 2017 | 6.75 Mn |
| Dec 31, 2016 | 10.26 Mn |
| Dec 31, 2016 | 10.26 Mn |